A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity

New treatment options may make “no evidence of disease activity” (NEDA: no relapses or disability progression and no new/enlarging MRI lesions, as opposed to “evidence of disease activity” (EDA) with at least one of the former), an achievable goal in relapsing-remitting multiple sclerosis (RRMS). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nygaard, Gro O., Celius, Elisabeth G., de Rodez Benavent, Sigrid A., Sowa, Piotr, Gustavsen, Marte W., Fjell, Anders M., Landrø, Nils I., Walhovd, Kristine B., Harbo, Hanne F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539191/
https://www.ncbi.nlm.nih.gov/pubmed/26280173
http://dx.doi.org/10.1371/journal.pone.0135974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539191/
https://www.ncbi.nlm.nih.gov/pubmed/26280173
http://dx.doi.org/10.1371/journal.pone.0135974

Ejemplares similares